The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

Data often pushes changes when technology makes it imperative that we do so, and today, we are seeing something we've never seen before; the...

Do you think artificial intelligence's foundation, evolution, and development owe much to cognitive neuroscience? If so, please reconsider your perspective, taking into account behavioral...

ARLINGTON, Va., Dec. 15, 2021 /PRNewswire/ -- An overwhelming number of parents support mental health education in schools and "mental health days" for their children, according...